Method for constructing an engineered bacterium for synthesizing fatty acids and derivatives thereof and application thereof
By enhancing the homologous recombination ability of Kluyveromyces martensii and modifying it with CRISPR-Cas9, an engineered strain capable of efficiently synthesizing fatty acids and their derivatives was constructed. This solved the problems of limitations in gene editing tools and the cost of adding exogenous oleic acid, and enabled efficient production and high yield at high temperatures.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- DALIAN UNIV OF TECH
- Filing Date
- 2024-12-12
- Publication Date
- 2026-06-12
AI Technical Summary
In the existing technology, the development of gene editing tools for Kluyveromyces martensii is limited, which restricts its potential as a chassis cell for chemical production. Furthermore, the synthesis of fatty acids and their derivatives requires the addition of exogenous oleic acid, which increases costs and results in low oleic acid conversion efficiency.
By enhancing the homologous recombination ability of Kluyveromyces martensii and using the CRISPR-Cas9 gene editing tool to modify its fatty acid metabolism pathway, including inactivating specific genes and integrating exogenous enzymes, an engineered strain capable of efficiently synthesizing fatty acids and their derivatives was constructed.
It enables the efficient synthesis of various fatty acids and their derivatives under high-temperature conditions, reducing production costs and increasing yield and conversion efficiency. It is applicable to the fields of daily chemicals, polymer monomers, food and feed.
Smart Images

Figure CN122189054A_ABST